{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:26:38Z","timestamp":1790011598100,"version":"4.0.1"},"reference-count":106,"publisher":"Elsevier","isbn-type":[{"value":"9780323992091","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/b978-0-323-99209-1.00017-x","type":"book-chapter","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T18:22:26Z","timestamp":1727115746000},"page":"355-366","source":"Crossref","is-referenced-by-count":11,"title":["Hematopoietic stem cell transplantation in leukodystrophies"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102566","article-title":"Multiparametric in vivo analyses of the brain and spine identify structural and metabolic biomarkers in men with adrenomyeloneuropathy","volume":"29","author":"Adanyeguh","year":"2021","journal-title":"NeuroImage Clin"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0015","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bbmt.2018.06.020","article-title":"Long-term functional outcomes after hematopoietic stem cell transplant for early infantile Krabbe disease","volume":"24","author":"Allewelt","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0020","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1073\/pnas.0306431101","article-title":"Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein","volume":"101","author":"Asheuer","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0025","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJM199006283222607","article-title":"Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation","volume":"322","author":"Aubourg","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-018-0872-9","article-title":"A prospective natural history study of Krabbe disease in a patient cohort with onset between 6 months and 3 years of life","volume":"13","author":"Bascou","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0035","doi-asserted-by":"crossref","first-page":"dmm048925","DOI":"10.1242\/dmm.048925","article-title":"The multicellular interplay of microglia in health and disease: lessons from leukodystrophy","volume":"14","author":"Berdowski","year":"2021","journal-title":"Dis Model Mech"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.biochi.2013.11.023","article-title":"Pathophysiology of X-linked adrenoleukodystrophy","volume":"98","author":"Berger","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0045","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/glia.23598","article-title":"Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy","volume":"67","author":"Bergner","year":"2019","journal-title":"Glia"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40348-020-00103-7","article-title":"Early clinical course after hematopoietic stem cell transplantation in children with juvenile metachromatic leukodystrophy","volume":"7","author":"Beschle","year":"2020","journal-title":"Mol Cell Pediatrics"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0055","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1001\/jamaoncol.2021.3676","article-title":"Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation over 4 decades: a blood or marrow transplant survivor study report","volume":"7","author":"Bhatia","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0060","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2015.00417","article-title":"Neuroinflammatory paradigms in lysosomal storage diseases","volume":"9","author":"Bosch","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13023-015-0313-y","article-title":"Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report","volume":"10","author":"Boucher","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0075","doi-asserted-by":"crossref","first-page":"E936","DOI":"10.1002\/humu.21093","article-title":"Characterization of new arylsulfatase A gene mutations reinforces genotype-phenotype correlation in metachromatic leukodystrophy","volume":"30","author":"Cesani","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0080","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/bloodadvances.2021005294","article-title":"Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy","volume":"6","author":"Chiesa","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0085","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tins.2016.03.005","article-title":"Emerging roles for CSF-1 receptor and its ligands in the nervous system","volume":"39","author":"Chitu","year":"2016","journal-title":"Trends Neurosci"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2020.07.002","article-title":"Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: results from a phase 1\/2 clinical trial","volume":"131","author":"Dali","year":"2020","journal-title":"Mol Genet Metab"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0095","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1212\/WNL.0000000000001074","article-title":"Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy","volume":"83","author":"De Beer","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0100","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/bmt.2010.252","article-title":"Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature","volume":"46","author":"de Hosson","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.895511","article-title":"Hematopoietic stem cell transplantation for neurological disorders: a focus on inborn errors of metabolism","volume":"16","author":"de Vasconcelos","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0110","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10545-012-9560-4","article-title":"Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review","volume":"36","author":"Debs","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0115","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.3390\/pharmaceutics14122778","article-title":"Hematopoietic stem cell transplantation in CSF1R-related leukoencephalopathy: retrospective study on predictors of outcomes","volume":"14","author":"Dulski","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0120","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.21391","article-title":"Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?","volume":"63","author":"Eichler","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0125","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/brain\/aww066","article-title":"CSF1R mosaicism in a family with hereditary diffuse leukoencephalopathy with spheroids","volume":"139","author":"Eichler","year":"2016","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0130","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management","volume":"7","author":"Engelen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0140","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1212\/WNL.0000000000201374","article-title":"International recommendations for the diagnosis and management of patients with adrenoleukodystrophy: a consensus-based approach","volume":"99","author":"Engelen","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0145","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/glia.24008","article-title":"Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy","volume":"69","author":"Feltri","year":"2021","journal-title":"Glia"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0150","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jimd.12388","article-title":"Metachromatic leukodystrophy: a single-center longitudinal study of 45 patients","volume":"44","author":"Fumagalli","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0155","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0160","doi-asserted-by":"crossref","first-page":"105087","DOI":"10.1016\/j.nbd.2020.105087","article-title":"Glial cells in the driver seat of leukodystrophy pathogenesis","volume":"146","author":"Garcia","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/awz390","article-title":"Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia","volume":"143","author":"Gelfand","year":"2020","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0030-1253412","article-title":"Metachromatic leukodystrophy\u2014an update","volume":"41","author":"Gieselmann","year":"2010","journal-title":"Neuropediatrics"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0175","series-title":"The online metabolic and molecular bases of inherited disease","article-title":"Metachromatic leukodystrophy","author":"Gieselmann","year":"2019"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.spen.2017.08.005","article-title":"Overview of inflammation in neurometabolic diseases","volume":"24","author":"Grabowski","year":"2017","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0185","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2016.2067","article-title":"Long-term outcome of allogeneic hematopoietic stem cell transplantation in patients with juvenile metachromatic leukodystrophy compared with nontransplanted control patients","volume":"73","author":"Groeschel","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0190","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/mds.29011","article-title":"Prophylactic allogeneic hematopoietic stem cell therapy for CSF1R-related leukoencephalopathy","volume":"37","author":"Horn","year":"2022","journal-title":"Mov Disord"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/brain\/awy299","article-title":"Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness","volume":"142","author":"Huffnagel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0200","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/jc.2018-01307","article-title":"The natural history of adrenal insufficiency in X-linked adrenoleukodystrophy: an international collaboration","volume":"104","author":"Huffnagel","year":"2019","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105862","article-title":"Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease","volume":"174","author":"Iacono","year":"2022","journal-title":"Neurobiol Dis"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0210","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.4049\/jimmunol.181.11.8077","article-title":"Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells","volume":"181","author":"Jeon","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0215","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1212\/01.wnl.0000436945.01023.ac","article-title":"De novo mutations in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)","volume":"81","author":"Karle","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0220","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1469-8749.2011.04028.x","article-title":"The natural course of gross motor deterioration in metachromatic leukodystrophy","volume":"53","author":"Kehrer","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0225","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.bbadis.2012.03.012","article-title":"X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects","volume":"1822","author":"Kemp","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0230","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrendo.2016.90","article-title":"Adrenoleukodystrophy\u2014neuroendocrine pathogenesis and redefinition of natural history","volume":"12","author":"Kemp","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0235","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood.V90.3.986","article-title":"Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model","volume":"90","author":"Kennedy","year":"1997","journal-title":"Blood"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0240","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrneurol.2017.175","article-title":"Adulthood leukodystrophies","volume":"14","author":"K\u00f6hler","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0245","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1474-4422(22)00495-1","article-title":"Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial","volume":"22","author":"K\u00f6hler","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0250","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1038\/s41436-019-0480-7","article-title":"Clinical characteristics of 248 patients with Krabbe disease: quantitative natural history modeling based on published cases","volume":"21","author":"Komatsuzaki","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/ene.13125","article-title":"Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation","volume":"24","author":"Konno","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0260","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.0000000000006642","article-title":"CSF1R-related leukoencephalopathy: a major player in primary microgliopathies","volume":"91","author":"Konno","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00281-004-0166-2","article-title":"Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases","volume":"26","author":"Krivit","year":"2004","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0270","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awx016","article-title":"Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy","volume":"140","author":"K\u00fchl","year":"2017","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0275","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0769","article-title":"Potential risks to stable long-term outcome of allogeneic hematopoietic stem cell transplantation for children with cerebral X-linked adrenoleukodystrophy","volume":"1","author":"K\u00fchl","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0280","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13023-018-0766-x","article-title":"Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease","volume":"13","author":"Kwon","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0285","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2478\/s13380-013-0118-1","article-title":"Astrocytes: emerging stars in leukodystrophy pathogenesis","volume":"4","author":"Lanciotti","year":"2013","journal-title":"Transl Neurosci"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0290","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jon.12502","article-title":"Hematopoietic stem cell transplantation in late-onset Krabbe disease: no evidence of worsening demyelination and axonal loss 4 years post-allograft","volume":"28","author":"Laule","year":"2018","journal-title":"J Neuroimaging"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0295","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.bmt.1705984","article-title":"Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease","volume":"41","author":"Lim","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0300","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/brain\/awx045","article-title":"Clinical and genetic characterization of leukoencephalopathies in adults","volume":"140","author":"Lynch","year":"2017","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0305","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1474-4422(07)70177-1","article-title":"Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study","volume":"6","author":"Mahmood","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0310","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11940-019-0605-y","article-title":"The landscape of hematopoietic stem cell transplant and gene therapy for X-linked adrenoleukodystrophy","volume":"21","author":"Mallack","year":"2019","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0315","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","article-title":"Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report","volume":"118","author":"Miller","year":"2011","journal-title":"Blood"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0320","first-page":"1375","article-title":"Haematopoietic stem cell transplantation in CSF1R-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia","volume":"90","author":"Mochel","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0325","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2000-9236","article-title":"X-linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients","volume":"31","author":"Moser","year":"2000","journal-title":"Neuropediatrics"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0330","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncpneuro0421","article-title":"X-linked adrenoleukodystrophy","volume":"3","author":"Moser","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0335","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/ijns8010016","article-title":"Newborn screening for X-linked adrenoleukodystrophy: past, present, and future","volume":"8","author":"Moser","year":"2022","journal-title":"Int J Neonat Screen"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0340","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0033-1364179","article-title":"Hematopoietic stem cell transplantation in the leukodystrophies: a systematic review of the literature","volume":"45","author":"Musolino","year":"2014","journal-title":"Neuropediatrics"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0345","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/jnr.23773","article-title":"A microglial hypothesis of globoid cell leukodystrophy pathology","volume":"94","author":"Nicaise","year":"2016","journal-title":"J Neurosci Res"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.902261","article-title":"Emerging cellular themes in leukodystrophies","volume":"10","author":"Nowacki","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0355","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1016\/j.bbmt.2019.09.003","article-title":"Hematopoietic stem cell transplantation to treat leukodystrophies: clinical practice guidelines from the Hunter's hope leukodystrophy care network","volume":"25","author":"Page","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0360","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1182\/bloodadvances.2020003418","article-title":"How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT","volume":"4","author":"Penack","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0365","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2003-10-3402","article-title":"Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999","volume":"104","author":"Peters","year":"2004","journal-title":"Blood"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0370","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1007\/s00415-016-8197-x","article-title":"CSF1R-related leukoencephalopathy mimicking primary progressive multiple sclerosis","volume":"263","author":"Prieto-Morin","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0375","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","article-title":"Microglia biology: one century of evolving concepts","volume":"179","author":"Prinz","year":"2019","journal-title":"Cell"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0380","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ng.1027","article-title":"Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids","volume":"44","author":"Rademakers","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0385","first-page":"3","article-title":"Krabbe disease: a personal perspective and hypothesis","volume":"12","author":"Rafi","year":"2022","journal-title":"Bioimpacts"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0390","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/mt.2015.145","article-title":"Long-term improvements in lifespan and pathology in CNS and PNS after BMT plus one intravenous injection of AAVrh10-GALC in twitcher mice","volume":"23","author":"Rafi","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0395","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1212\/01.wnl.0000234129.97727.4d","article-title":"Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype","volume":"67","author":"Rauschka","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0400","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbmt.2018.09.036","article-title":"Survival and functional outcomes in boys with cerebral adrenoleukodystrophy with and without hematopoietic stem cell transplantation","volume":"25","author":"Raymond","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0405","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.celrep.2017.07.004","article-title":"The lifespan and turnover of microglia in the human brain","volume":"20","author":"R\u00e9u","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0410","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2017.07.004","article-title":"Overview of immune abnormalities in lysosomal storage disorders","volume":"188","author":"Rigante","year":"2017","journal-title":"Immunol Lett"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0415","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41591-022-01691-9","article-title":"Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain","volume":"28","author":"Sailor","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0420","article-title":"Natural history of a cohort of ABCD1 variant female carriers","volume":"26","author":"Schirinzi","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0425","first-page":"25","article-title":"Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: the European Metachromatic Leukodystrophy initiative (MLDi)","volume":"17","author":"Schoenmakers","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0430","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0435","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1038\/s41467-018-07548-5","article-title":"Engrafted parenchymal brain macrophages differ from microglia in transcriptome, chromatin landscape and response to challenge","volume":"9","author":"Shemer","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0440","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pediatrneurol.2020.06.005","article-title":"Elevated leukodystrophy incidence predicted from genomics databases","volume":"111","author":"Soderholm","year":"2020","journal-title":"Pediatr Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0445","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/mt.2015.69","article-title":"Anti-inflammatory therapy with simvastatin improves neuroinflammation and CNS function in a mouse model of metachromatic leukodystrophy","volume":"23","author":"Stein","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0450","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczy\u0144ski","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0455","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/08830738030180090201","article-title":"Globoid cell leukodystrophy (Krabbe's disease): update","volume":"18","author":"Suzuki","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0460","doi-asserted-by":"crossref","first-page":"24579","DOI":"10.1038\/srep24579","article-title":"Cerebral spinal fluid levels of cytokines are elevated in patients with metachromatic leukodystrophy","volume":"6","author":"Thibert","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0465","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1002\/mds.28734","article-title":"Treatment of CSF1R-related leukoencephalopathy: breaking new ground","volume":"36","author":"Tipton","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0470","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/bloodadvances.2017010645","article-title":"Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies","volume":"2","author":"Van Den Broek","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0475","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-017-1739-1","article-title":"Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms","volume":"134","author":"Van der Knaap","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0480","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1474-4422(19)30143-7","article-title":"Diagnosis, prognosis, and treatment of leukodystrophies","volume":"18","author":"Van Der Knaap","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0485","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","article-title":"Common and uncommon pathogenic cascades in lysosomal storage diseases","volume":"285","author":"Vitner","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0490","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jimd.12044","article-title":"Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning for adult cerebral X-linked adrenoleukodystrophy","volume":"42","author":"Waldh\u00fcter","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0495","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/gim.2016.35","article-title":"Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State","volume":"18","author":"Wasserstein","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0500","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/brain\/awy127","article-title":"Impaired plasticity of macrophages in X-linked adrenoleukodystrophy","volume":"141","author":"Weinhofer","year":"2018","journal-title":"Brain"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0505","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/s41467-021-22114-2","article-title":"Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy","volume":"12","author":"Weinhofer","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0510","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuron.2020.03.031","article-title":"Macrophages expressing GALC improve peripheral Krabbe disease by a mechanism independent of cross-correction","volume":"107","author":"Weinstock","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0515","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/acn3.50975","article-title":"Metachromatic leukodystrophy and transplantation: remyelination, no cross-correction","volume":"7","author":"Wolf","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0520","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1212\/WNL.0000000000004418","article-title":"Developmental outcomes of cord blood transplantation for Krabbe disease: a 15-year study","volume":"89","author":"Wright","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0525","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1182\/blood.2020005477","article-title":"Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease","volume":"137","author":"Yoon","year":"2021","journal-title":"Blood"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0530","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12987-022-00316-0","article-title":"The neurovascular unit in leukodystrophies: towards solving the puzzle","volume":"19","author":"Zarekiani","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/B978-0-323-99209-1.00017-X_bb0535","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/mds.29068","article-title":"The first allogeneic hematopoietic stem cell transplantation in a polish patient with adult-onset leukoencephalopathy with spheroids and pigmented glia","volume":"37","author":"\u017bur-Wyrozumska","year":"2022","journal-title":"Mov Disord"}],"container-title":["Handbook of Clinical Neurology","Inherited White Matter Disorders and Their Mimics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B978032399209100017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B978032399209100017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:55:05Z","timestamp":1753880105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B978032399209100017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780323992091"],"references-count":106,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-99209-1.00017-x","relation":{},"ISSN":["0072-9752"],"issn-type":[{"value":"0072-9752","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}